Schedule 13D ownership disclosure

RXi Pharmaceuticals Corp

Security class unavailable · CUSIP: 74979C105

Event date: 2016-04-18

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
3.4300%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-006839
Form type
SC 13D/A
Filer
OPKO HEALTH, INC.
CIK
CIK 944809
Filed
Jan 10, 2017
Reporting period
Apr 18, 2016
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub